Lineage Cell Return On Asset vs. Net Income
| LCTX Stock | USD 0.50 0.10 16.67% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.97 | 0.925 |
|
|
For Lineage Cell profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Lineage Cell to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Lineage Cell Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Lineage Cell's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Lineage Cell Therapeutics over time as well as its relative position and ranking within its peers.
Lineage |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lineage Cell. If investors know Lineage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lineage Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.08) | Revenue Per Share 0.034 | Quarterly Revenue Growth (0.56) | Return On Assets (0.13) | Return On Equity (0.35) |
The market value of Lineage Cell Therapeutics is measured differently than its book value, which is the value of Lineage that is recorded on the company's balance sheet. Investors also form their own opinion of Lineage Cell's value that differs from its market value or its book value, called intrinsic value, which is Lineage Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lineage Cell's market value can be influenced by many factors that don't directly affect Lineage Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lineage Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lineage Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lineage Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lineage Cell Therapeutics Net Income vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Lineage Cell's current stock value. Our valuation model uses many indicators to compare Lineage Cell value to that of its competitors to determine the firm's financial worth. Lineage Cell Therapeutics is rated below average in return on asset category among its peers. It is rated below average in net income category among its peers . Lineage Cell reported Net Loss of (21.49 Million) in 2023. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lineage Cell's earnings, one of the primary drivers of an investment's value.Lineage Net Income vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Lineage Cell |
| = | -0.13 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Lineage Cell |
| = | (21.49 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Lineage Net Income Comparison
Lineage Cell is currently under evaluation in net income category among its peers.
Lineage Cell Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Lineage Cell, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Lineage Cell will eventually generate negative long term returns. The profitability progress is the general direction of Lineage Cell's change in net profit over the period of time. It can combine multiple indicators of Lineage Cell, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -3.1 M | -2.9 M | |
| Operating Income | -24.7 M | -26 M | |
| Income Before Tax | -23.3 M | -22.1 M | |
| Total Other Income Expense Net | 1.5 M | 1.4 M | |
| Net Loss | -21.5 M | -20.4 M | |
| Income Tax Expense | -1.8 M | -1.9 M | |
| Net Loss | -21.5 M | -22.6 M | |
| Non Operating Income Net Other | -4.7 M | -4.5 M | |
| Net Loss | -30.2 M | -31.7 M | |
| Interest Income | 1.6 M | 1.5 M | |
| Net Interest Income | 1.6 M | 1.7 M | |
| Change To Netincome | 4.8 M | 5.1 M | |
| Net Loss | (0.12) | (0.13) | |
| Income Quality | 1.33 | 0.80 | |
| Net Income Per E B T | 0.92 | 1.23 |
Lineage Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Lineage Cell. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Lineage Cell position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Lineage Cell's important profitability drivers and their relationship over time.
Use Lineage Cell in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lineage Cell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will appreciate offsetting losses from the drop in the long position's value.Lineage Cell Pair Trading
Lineage Cell Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Lineage Cell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lineage Cell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lineage Cell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lineage Cell Therapeutics to buy it.
The correlation of Lineage Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lineage Cell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lineage Cell Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lineage Cell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Lineage Cell position
In addition to having Lineage Cell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run ESG Investing Thematic Idea Now
ESG Investing
Sustainable investments that promote the conservation of the natural world, social resposibility, freindly employees policies and strong governance. The ESG Investing theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ESG Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Lineage Stock Analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.